Industry Type: ALL Conventional Industry High-Tech Industry Service Industry Emerging Industry    Title:  

Food Biotechnology Industry 2019-Apr Doc　#30670 Industry Report (condensed version) US$100 Both output and sales of the industry are expected to maintain a steady growth, while demand for functional beverages and dietary supplements will remain strong in China, prompting major industry participants to be active in expanding the production lines. Food Biotechnology Industry 2018-Jun Doc　#29121 Industry Report (condensed version) US$100 Boosted by a sharp increase in demand for dietary Supplement in China, Taiwanese firms, Grape King Inc. and TCI Bio Corporation Limited Corporation Limited continue to develop plans to build factories and explore the China market. Regenerative Medicine 2017-Mar Doc　#27026 Industry Report (condensed version) US$75 Although the industry is expected to see a slight growth in output value, ranging from 3 percent to 5 percent, the industry is still in its embryonic stage. Food Biotechnology Industry 2016-Dec Doc　#26450 Industry Report (condensed version) US$75 China’s nutritional food improves and will contribute to a steady growth in the production value of Taiwan’s food biotechnology industry in 2017. Regenerative Medicine Industry 2016-Jun Doc　#25563 Industry Report (condensed version) US$75 The industry’s output value is expected to rise marginally by 3 – 5 percent year-on-year in the first half of 2016. Agricultural Biotechnology Industry 2016-Jan Doc　#24872 Industry Report (condensed version) US$75 In the first ten months of 2015, Taiwan’s exports of bottle orchid seedlings fell by 4.53 percent in value because of China’s ban on imports. However, other animal vaccines enjoyed a strong growth, and Taiwan’s effort to support the agricultural biotechnology industry lifted other animal vaccines industry. Regenerative Medicine 2015-Oct Doc　#24378 Industry Report (condensed version) US$75 Both output and sales values of the industry will still contract in the third quarter of 2015 from the same period a year earlier as a consequence of weaker-than-expected export to China and a decline in the prices of cotton yarn products. Western Medicines and Biopharmaceuticals 2015-Sep Doc　#24268 Industry Report (condensed version) US$75 The industry sales would rise in value in the final quarter of 2015 from a year earlier, and growth would range between 1 percent and 3 percent. Raw Material Medicine Manufacturing 2015-Aug Doc　#24137 Industry Report (condensed version) US$75 Despite poor domestic sales of the industry, firms within the industry continue to launch new products. Additionally, customers in Europe, India, and Japan keep restocking, suggesting the industry’s sales growth would range between 2 percent and 4 percent in the second half of 2015. Food Biotechnology Industry 2015-Mar Doc　#23538 Industry Report (condensed version) US$75 The industry’s production value is expected to rise by 6 to 9 percent in 2015, thanks to stable growth in the domestic market, expansion of export markets, and plans by a number of firms to engage in high margin capsule and tablet nutritional supplements.  First  Previous  Next  Last  In  1  /  4  Page  (Find  34  records)

Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543